Current partner codePEPTIDESDE
PeptideStat
Menu

Vendors

Compare pricesVendor directoryVendor reviewsDiscount codesLab tests & COAs

Research

ResearchDatabaseClinical trials

Tools

All calculatorsReconstitutionAccumulationUnit converterPeptide chemistry

Therapeutic-area index

Weight lossPeptide Trials.

Explore peptide clinical trials tagged to the weight loss condition group in the current local registry snapshot. Condition groups are PeptideStat search classifications layered over source-reported indications.

Studies
371
Recruiting
100
Completed
169
Results posted
52
Countries
56
Avg enrollment
360

Velocity

Weight loss trials by start year

Study start year · indexed snapshot

93704723020012001: 2 trials2002: 1 trials2003: 0 trials2004: 1 trials2005: 4 trials20062006: 4 trials2007: 3 trials2008: 6 trials2009: 0 trials2010: 0 trials20112011: 2 trials2012: 2 trials2013: 3 trials2014: 4 trials2015: 4 trials20162016: 3 trials2017: 6 trials2018: 10 trials2019: 5 trials2020: 7 trials20212021: 18 trials2022: 24 trials2023: 38 trials2024: 56 trials2025: 72 trials20262026: 93 trials20272027: 3 trials

Development

Trials by phase

Early Phase 13
Phase 195
Phase 287
Phase 386
Phase 439

Industry

Leading sponsors

Novo Nordisk58
Eli Lilly43
Amgen24
Rhythm Pharmaceuticals, Inc.21
Boehringer Ingelheim18
Innovent Biologics (Suzhou) Co. Ltd.14
AstraZeneca10
Altimmune, Inc.6

Therapeutic areas

Condition groups

Weight loss371
Type 2 diabetes39
Inflammation11
Brain health7
Longevity7
Muscle growth3
Pain3
Crohn's1

Compound leaders

Most represented peptides.

01Tirzepatide5402Semaglutide4803Glucagon4304Liraglutide3605Cagrilintide2906Maridebart cafraglutide2407Mazdutide2308Setmelanotide2309Amycretin1910Survodutide1811Dulaglutide1712Eloralintide17

Study explorer

Search this collection.

371 matching studies